Bernstein’s Nandan Kulkarni also discusses India’s drug discovery capabilities and the growth outlook for GLP-1 weight loss medicines.
Bernstein’s Nandan Kulkarni also discusses India’s drug discovery capabilities and the growth outlook for GLP-1 weight loss medicines.